Saito Kosuke, Maekawa Keiko, Kinchen Jason M, Tanaka Rieko, Kumagai Yuji, Saito Yoshiro
Division of Medicinal Safety Science, National Institute of Health Sciences.
Biol Pharm Bull. 2016;39(7):1179-86. doi: 10.1248/bpb.b16-00226.
Serum metabolites can reflect the diffusion/export of biochemicals from various organs. They can serve as biomarkers related to diseases and therapeutic efficacy/toxicity. While studies in Caucasians suggested that subject gender and age can affect circulating metabolite profiles, the Japanese population has not been surveyed. Our objective was to delineate gender- and age-associated differences in serum metabolite profiles among Japanese populations. Using a mass spectrometry-based global metabolomics approach, 516 endogenous metabolites were detected in sera from Japanese individuals. The principal component analysis identified gender as the primary component, followed by age, suggesting that these two criteria were key contributors to variations in the dataset. Gender-associated differences were observed in 31 and 25% of metabolites in the young (age 25-35) and old (ages 55-65) populations, respectively, in redox homeostasis, and in steroid and purine nucleotide metabolism pathways. Age-associated differences were observed in 24 and 23% of metabolites in men and women, respectively. No pathway was commonly highlighted. Thus, gender and age impact on metabolite profiles in the Japanese population. Our results provide useful information to explore biomarkers for clinical applications in the Japanese population and to assess the applicability of known biomarkers identified in other populations to the Japanese population.
血清代谢物能够反映生物化学物质从各个器官的扩散/输出情况。它们可作为与疾病及治疗效果/毒性相关的生物标志物。虽然针对高加索人的研究表明,受试者的性别和年龄会影响循环代谢物谱,但尚未对日本人群进行过调查。我们的目标是描绘日本人群血清代谢物谱中与性别和年龄相关的差异。采用基于质谱的全局代谢组学方法,在日本个体的血清中检测到了516种内源性代谢物。主成分分析确定性别是主要成分,其次是年龄,这表明这两个标准是数据集中变异的关键因素。在年轻人群(25 - 35岁)和老年人群(55 - 65岁)中,分别有31%和25%的代谢物在氧化还原稳态以及类固醇和嘌呤核苷酸代谢途径中存在与性别相关的差异。在男性和女性中,分别有24%和23%的代谢物存在与年龄相关的差异。没有共同突出的途径。因此,性别和年龄会影响日本人群的代谢物谱。我们的结果为探索日本人群临床应用中的生物标志物以及评估在其他人群中鉴定出的已知生物标志物对日本人群的适用性提供了有用信息。